Cargando…
Basal Forebrain Volume, but Not Hippocampal Volume, Is a Predictor of Global Cognitive Decline in Patients With Alzheimer's Disease Treated With Cholinesterase Inhibitors
Background: Predicting the progression of cognitive decline in Alzheimer's disease (AD) is important for treatment selection and patient counseling. Structural MRI markers such as hippocampus or basal forebrain volumes might represent useful instruments for the prediction of cognitive decline....
Autores principales: | Teipel, Stefan J., Cavedo, Enrica, Hampel, Harald, Grothe, Michel J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6104491/ https://www.ncbi.nlm.nih.gov/pubmed/30158893 http://dx.doi.org/10.3389/fneur.2018.00642 |
Ejemplares similares
-
Reduced basal forebrain atrophy progression in a randomized Donepezil trial in prodromal Alzheimer’s disease
por: Cavedo, Enrica, et al.
Publicado: (2017) -
Neuropathologic features associated with basal forebrain atrophy in Alzheimer disease
por: Teipel, Stefan J., et al.
Publicado: (2020) -
Subregional volume reduction of the cholinergic forebrain in subjective cognitive decline (SCD)
por: Scheef, Lukas, et al.
Publicado: (2018) -
Hippocampus and basal forebrain volumes modulate effects of anticholinergic treatment on delayed recall in healthy older adults
por: Teipel, Stefan J., et al.
Publicado: (2015) -
Cholinergic Basal Forebrain Volumes Predict Gait Decline in Parkinson's Disease
por: Wilson, Joanna, et al.
Publicado: (2020)